EUVIMEDEUVIMED entdecken
Crossref

miR-19a-3p and miR-19b-3p promote microglia activation associated with neuroinflammation following spinal cord injury

Faezeh Sahebdel, Leslie Morse, Ricardo Battaglino, Julie K Olson

The Journal of Immunology · 01.05.2023 · 210 (Supplement_1) · 167.21-167.21

DOI: 10.4049/jimmunol.210.supp.167.21 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 01.05.2023. Verfasst von Faezeh Sahebdel und 3 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spinal cord injury (SCI)-induced neuropathic pain represents a significant clinical challenge that affects 10 to 30% of injured persons. Following SCI, microglia activation promotes neuroinflammation through the production of pro-inflammatory cytokines which has been suggested to play a role in neuropathic pain. MicroRNAs (miRs) can be molecular mediators of neuroinflammation. Our group has shown elevated levels of circulating miR-19a and miR-19b in persons living with chronic pain following SCI. We wanted to determine whether miR-19a and miR-19b are involved in neuroinflammation mediated by activated microglia after SCI. Microglia were incubated with inflammatory stimuli in the presence of miR-19a or miR-19b mimics and analyzed for activation. Microglia activation was enhanced in the presence of miR-19a or miR-19b mimics with increased expression of pro-inflammatory cytokines and decreased expression of suppressor of cytokine signaling, SOCS1 and SOCS3. Further, our results show enhanced signaling via NF-kB and Jak pathways. Overall, our results showed that treatment of microglia with miR-19a or miR-19b inhibited SOCS1 and SOCS3 expression and promoted expression of pro-inflammatory cytokines resulting in enhanced microglia activation. These results suggest that increased expression of miR-19a and miR-19b after SCI may be promoting neuroinflammation through activation of the microglia which contributes to neuropathic pain. These results may be useful in developing therapies targeting miRNAs to control neuroinflammation and neuropathic pain in persons living with SCI. This study was supported by the Department of Defense (W81XWH-10-1-1043), National Institutes of Health (R01AR064793) and The National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR, 90SI5015-01-00)

Zitieren

APA

Sahebdel, F., Morse, L., Battaglino, R., & Olson, J. K. (2023). miR-19a-3p and miR-19b-3p promote microglia activation associated with neuroinflammation following spinal cord injury. The Journal of Immunology, 210(Supplement_1), 167.21-167.21. https://doi.org/10.4049/jimmunol.210.supp.167.21

Vancouver

Sahebdel F, Morse L, Battaglino R, Olson JK. miR-19a-3p and miR-19b-3p promote microglia activation associated with neuroinflammation following spinal cord injury. The Journal of Immunology. 2023;210(Supplement_1):167.21-167.21. doi:10.4049/jimmunol.210.supp.167.21

BibTeX
@article{Sahebdel2023,
  author = {Sahebdel, Faezeh and Morse, Leslie and Battaglino, Ricardo and Olson, Julie K},
  title = {miR-19a-3p and miR-19b-3p promote microglia activation associated with neuroinflammation following spinal cord injury},
  journal = {The Journal of Immunology},
  year = {2023},
  volume = {210},
  number = {Supplement_1},
  pages = {167.21--167.21},
  doi = {10.4049/jimmunol.210.supp.167.21}
}
Kostenlos starten →